Skip to content
  • About Us
    • Find out more about us
    • Sustainability
  • Services
    • Clinical Home Nursing Services
      • IV Services
      • Chemotherapy in the Home
      • Patient Training & Education
      • OPAT - IV Antibiotics at Home
    • Speciality Pharmaceutical Supply Chain
      • Direct to Patient Distribution
      • Cold Chain Systems
      • Track n' Trace Systems
      • Haemophilia
      • Pharmacy Services
      • Rare Disease / Orphan Products
    • Market access
      • Managed Access Programmes (pre reimbursement)
      • Early Access Programmes
    • Community Infusion & Venesection Units (CIVU)
    • Sharps Waste Management Services
    • Compliance
  • New Offerings
    • Virtual App
    • TCP Homecare Referral
  • Careers
  • Contact Us
    TCP Homecare
    • About Us
      • Find out more about us
      • Sustainability
    • Services
      • Clinical Home Nursing Services
        • IV Services
        • Chemotherapy in the Home
        • Patient Training & Education
        • OPAT - IV Antibiotics at Home
      • Speciality Pharmaceutical Supply Chain
        • Direct to Patient Distribution
        • Cold Chain Systems
        • Track n' Trace Systems
        • Haemophilia
        • Pharmacy Services
        • Rare Disease / Orphan Products
      • Market access
        • Managed Access Programmes (pre reimbursement)
        • Early Access Programmes
      • Community Infusion & Venesection Units (CIVU)
      • Sharps Waste Management Services
      • Compliance
    • New Offerings
      • Virtual App
      • TCP Homecare Referral
    • Careers
    Contact Us

    Item added to your cart

    View cart

    Managed Access Programmes (pre reimbursement)

    › Services › Market access › Managed Access Programmes (pre reimbursement)

    In today’s highly cost-conscious Irish pharmaceutical marketplace, one of the greatest challenges for all stakeholders is how new products are funded.  For many companies with exciting new products, there can be a significant gap between IMB licence approval and confirmation of HSE reimbursement status. TCP Group has been working with many leading biotech and pharmaceutical companies to devise launch strategies for specialist products in a highly controlled manner, while also providing clear data on levels of prescribing and patient numbers.

    TCP Group can take control of your specialist product supply chain, therefore enabling you to build up further pharmacoeconomic data to secure reimbursement. Some of the areas we have worked with the leading pharmaceutical companies are:

    • Direct to patient distribution
    • Risk share / Conditional reimbursement programmes
    • Homecare patient support programmes

    Talk to us today about your market access strategy for your specialist products.

    TCP Homecare

    • About Us
    • Careers
    • Gender Pay Gap Report
    • Contact Us
    • Sustainability

    Services

    • Clinical Home Nursing Services
    • Speciality Pharmaceutical Supply Chain
    • Market access
    • Community Infusion & Venesection Units (CIVU)
    • Sharps Waste Management Services
    • Compliance

    Legal

    • Set cookie preferences
    • Cookie Policy
    • Terms & Conditions
    • Privacy Policy
    • Code of Conduct

    +353 1 429 1828

    Phone

    +353 1 429 8721

    Fax

    LinkedIn

    connect

    © 2025, TCP Homecare | a PHOENIX company
    • Choosing a selection results in a full page refresh.
    • Opens in a new window.